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Summary
We examined the role of cytokines in the cutaneous response to the application of trinitro-
chlorobenzene (TNCB) in both nonsensitized and sensitized mice, i .e ., in the irritant reaction
(IR) and contact hypersensitivity reactions (CH) . When administered immediately before challenge,
anti-tumor necrosis factor (TNF) antibody abrogated the ear swelling response in CH ; antibody
directed against interferony or antibodies to both granulocyte/macrophage colony-stimulating
factor and interleukin 3 (IL3) had a partial inhibitory effect ; anti-IIr2 receptor antibody had
no effect . AntiTNF prevented the various features of the CH, as seen on histological sections,
e.g., leukocyte infiltration and hemorrhages within the dermis and keratinocytes necrosis. Anti-
TNF antibody also prevented the IR . The presence ofTNFmRNA was evaluated on Northern
blots ; TNF-ci mRNA was detectable in an untreated ear, increased after the application ofTNCB
in nonsensitized mice, and was highest in sensitized mice. TNF mRNA accumulation, which
was evident 0.5 h after hapten application and lasted >72 h, was abolished by treatment with
antiTNF antibody, thus suggesting an auto-amplification ofTNF production . The cellular origin
ofTNFmRNA was explored by in situ hybridization ; basal keratinocytes showed the highest
labeling, but TNF mRNA was also detectable in cells ofthe dermal infiltrate. After hapten (TNCB)
application at sites susceptible (the ear) or resistant (the foot pad) to CH or IR, a close correlation
was observed betweenTNFmRNA accumulation and the intensity ofthe inflammatory reaction .
The major role played by TNF in both the CH and the IR explains the histologically similar
aspects ofthese reactions and the extreme variability of these reactions at various anatomical sites.
T
he epicutanous application ofhighly reactive compounds
(haptens) to the skin can elicit two types of reactions ;
the primary "irritant" reaction (IR)t and the contact hyper-
sensivity reaction (CH) when the subject has been previously
sensitized (1-3). The ability of a chemical contactant to in-
duceCH and IR is related to its ability to couple covalently
to a protein of the skin (4) . Histologically, IR and CH are
characterized by vasodilation, the extravasation ofleukocytes
in the upper dermis (i.e., monocytes, polymorphs, and eo-
sinophils), and epidermal alterations such as keratinocyte
damage (5, 6) .
T lymphocytes play an inductive role in CH as well as in
other delayed-type hypersensitivity (DTH) reactions elicited
by the subcutaneous injection of antigen . The CH is depen-
dent upon T lymphocytes of the CD8+ phenotype (7),
in contrast to the DTH, which is mainly dependent upon
'Abbreviations used in this paper : CH, contact hypersensitivity reaction ;
DTH, delayed-type hypersensitivity; GM, granulocyte/macrophage ; IR,
irritant reaction .
the CD4+ subset (8) . T lymphocytes of either the CD4 or
CD8 subset secrete a large variety of cytokines that might
be involved in the inflammatory reaction ofCH (9, 10) . In
this report, we investigated the role of TNF-oi as well as that
of IIr2, Ils3, granulocyte/macrophage (GM)-CSF and IFN-y
in the elicitation phase of the CH by studying the effect of
anticytokine antibody on the skin response to the applica-
tion of hapten . AntiTNF antibody treatment was the most
effective inhibitor ofCH ; this treatment also blocked theIR .
Both reactions were associated with an accumulation ofTNF
mRNA within basal keratinocytes and dermal infiltrate, as
shown by Northern blotting and in situ hybridization .
Materials and Methods
Mice .
￿
CBA/Ca mice were purchased from Olac Ltd., Bicester,
UK, and were bred in our animal facility.
Contact Hypersensitivity .
￿
Mice were sensitized by an abdominal
application of 0.05 ml of trinitrochlorobenzene (TNCB) (Poly-
sciences, Inc., Warrington, PA) at 7% in olive oil/acetone (4:1) .
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in olive oilon the inner face ofthe ear. Oxazolone (ethoxymethyl-
ene-2 phenyl oxazolone;SigmaChemicalCo., St . Louis, MO) was
applied at thesame concentration as TNCB. The reaction was evalu-
ated by measuring the ear thickness with a micrometer (Oditest,
HC Kroeplin GMBH, FRG) .
Histology .
￿
The ears were fixedby immersion in2% glutaralde-
hyde in 0.1 M cacodylate buffer. Tissues were embedded in
methylmetacrylate, and 3-pin sections were stained with hema-
toxylin-eosin . Semi-quantitative evaluation of epidermal cell necrosis
was performed by scoring the number of sebaceous glands with
more than three necrotic cells. The intensity of the dermal infiltrate
was evaluated by counting the number of dermal leukocytes per
microscopic field at 1,000-fold magnification.
RNAAnalysis.
￿
After deathbycervical dislocation, the ears were
immediately frozen in liquid nitrogen . They were minced in guani-
dine thiocyanate, and the RNA was isolated by guanidine-thio-
cyanate/cesium chloride centrifugation (11) . Northern blots were
performed as described, using "P-labeled mRNA obtained from
a sP64 (or 6i plasmid) containing the 696 Taq-EcoRl fragment of
the mouse TNF gene (11) . Northern gels were analyzed with
genoscan 1.3 (Genofit S.A., Geneva, Switzerland) .
In Situ Hybridization.
￿
Either frozen sections or sections from
formaldehyde-fixed andparaffin-embedded tissue were hybridized
with a "S-labeled TNFcRNA probe (12) . Sections were first ex-
posed to aphotographic film and subsequently dipped in an emul-
sion (Ilford Scientific Product Limited, Mobberley, Cheshire, UK).
Rabbit Anti-mouse CytokineAntibodies.
￿
TNF-awas akind gift
fromB. Allet, Glaxo, IMB, Geneva . IFN-.ywas a gift fromG. Adolf,
Genetech &Boehringer, Vienna, Austria . ID3 was a gift fromG .
Schrimcher, Glaxo IMB . GM-CSF wasa gift from J. DeLamarter,
Glaxo IMB. Antibodies were prepared in rabbits by the repeated
injections ofrecombinant cytokines in CFA, as previously described
(13-15). The IgG fraction was ultracentrifuged (150,000 g for 120
min) before injection. These antibodies have been previously shown
to be effective in other in vivo models (13-15). Approximately 10
Effect ofAnticytokine Antibodies on the Hypersensitivity and
Irritant Reactions. TNCB-sensitized mice were injected with
antibodies 4 h before challenge with TNCB. The effect on
the ear swelling response is presented in Table 1. AntiTNF
antibody had the most clear-cut effect of the anticytokine
antibodies tested; it abrogated the CH in all eight experi-
ments performed (p< 10 -4 in all experiments) . Anti-GM-
CSF and anti-I1,3were used in combination since their effects
are in part overlapping and since only their combined ad-
ministration has been found effective inT lymphocyte-in-
duced immunopathological reactions (14) . These antibodies
had a moderate inhibitory effect upon the CH which was
significant (p < 0.05) in two of four different experiments .
Anti-IFN-y antibodies (eithermAb or rabbit IgG) produced
a moderate decrease of the reaction, which was significant
at ap< 0.05 in four of five experiments . Anti-IIT2R mAb
had no detectable effect .
In these experiments performed with sensitized mice, the
increased ear thickness was calculated from the response
obtained in nonsensitized mice (i.e., the IR), which was
used as acontrol. Unexpectedly, itwas observed that the re-
sponse of sensitized and antiTNF-treated mice was below
zero. Therefore, the possibility that theinflammatory response
1Lg of theIgG fraction was able to neutralize the biological activity
of 1 P.g of the purified cytokine .
Monoclonal Antibodies .
￿
In this study, we used mAbs for rat
anti-murine IFN-y(R46A2) (16) and rat anti-mouse IIr2R (PC61)
(17) . These mAbs have been found to be effective in vivo (15, 18).
Statistical Evaluation .
￿
The difference between two means was
evaluated by the nonparametric Mann and Whitney U test .
Results
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The results of the ear swelling response are the mean (+ SD) ofthe values of a representative experiment obtained 24 h after application (six mice/group) .
Antibodies were injected immediately before challenge .
In nonsensitized animals, the ear swelling was measured in comparison with that of control, treated with the solvent (acetone/oid), while in sensi-
tized animals, the swelling was measured in comparison with the response to TNCB of nonsensitized mice .
t Range of inhibition observed in three to five experiments.
Sp< 10-z.
li p< 10-4 .
Table 1 .
Priming
Effect of Anticytokine Antibodies
Challenge
(TNCB)
on Cutaneous CH and IR
Treatment Ear thickness" Inhibition*
/ 00 1
+ 0.1 Nonimmune Ig 75 (6) (0)
+ 0.1 Anti-TNF 0 0 1 86-100
+ 0.1 Anti-GM + IL-3 68 (12) 9-35
+ 0.1 Anti-IFN-.y 49 (7) 18-58
+ 0.1 Anti-IL-2R 89 (14) 0-0
0 0 0 () -
0.1 0 21 (3) -
1 .0 Nonimmune Ig 43 (5) (0)
1 .0 Anti-TNF 3 (1)II 61-93produced by TNCB in nonsensitized mice (i.e., the IR) was
also influenced by antiTNF was explored . As shown in Table
1, the IR was clearly inhibited by the antiTNF antibody
treatment .
Histological Evaluation .
￿
Application ofTNCB to the ear
of sensitized mice produced both epidermal and dermal al-
terations (Fig. 1 and Table 2) . In the epidermis, it elicited
necrosis of isolated or grouped keratinocytes (Fig. 1, D-F) .
In addition, necrosis was also evident in the hair follicles and
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Figure 1 . Ear sections from
TNCB-sensitized mice killed 24 h
after application ofTNCB to the
inner face ofthe ear. (A and B) Mice
treated with nonimmune (A) or
antiTNF (B) rabbit IgG (H and E ;
02) . Dermis (d), striated muscle
(m), andear cartilage (c) are recog-
nizable. In A, the dermis of the
inner side is edematous and heavily
infiltrated with leukocytes and a hair
follicle is necrotic (arrow) ; while in
B, the epidermis does not show al-
terations and a moderate leukocytic
infiltration of the inner face of the
ear is evident . (C-F) Epithelial al-
terations of mice treated with anti-
TNF (C) or normal IgG (D-F) (H
andE; x202) . In C, a hair follicle
centered around the hair (h) with
two sebaceous glands does not show
evident alterations . (D) The infil-
trated dermis and a hair follicle
present both an apparently isolated
necrosis (arrow) and a more massive
necrotic formation (asterisk) . (E)
The epidermis present a well-demar-
cated necrotic formation (asterisk) as
well as more isolated cell necrosis .
(F) Hair follicle, whose hair is recog-
nizable (h), is completely necrotic
(asterisk) .
sebaceous glands (Fig. 1,D and F) . Since necroses are mul-
tifocal and heterogeneous in size, the precise quantification
of the entire epidermal damage was difficult. Therefore a semi-
quantitative evaluation was performed on the sebaceous gland
only (Table 2) . In the dermis, edema, occasionally associated
with hemorrhages and polynuclear leukocyte infiltration, was
evident (Fig . 1, A and B) . These epidermal and dermal alter-
ations were observed in both naive and sensitized mice: e.g.,
challenge of a nonsensitized mice with 1% TNCB producedTable 2.
￿
Histological Evaluation of the Effect of Anti-TNF
on CH and IR
Results are the mean (+ SD) of the values observed in greater than five
mice .
" Epithelial necrosis is the percentage of sebaceous glands with more than
three necrotic cells .
t Number of dermal leukocytes per microscopic field.
S Application of acetone/oil .
II p < 10-z .
lesions similar to those observed with 0.1% TNCB applied
upon the ear of TNCB-sensitized mice.
Administration of antiTNF antibody reduced all the com-
ponents (i .e., dermal and epidermal) of the CH and the IR
(Fig. 1, A and B, and Table 2) .
Expression ofTNF-a mRNA .
￿
After extraction of whole
ear RNA, the content of TNF mRNA was evaluated on
Northern blots. TNFmRNA was detectable in normal ears
and was gradually increased by the topical application of the
solvent (acetone/oil), ofTNCB in nonsensitized recipients,
and ofTNCB in sensitized mice, as seen 24 h after applica-
tion (Fig. 2) . RNA extracted various times after application
Figure 2 .
￿
Expression of TNF-amRNA in the whole ear RNA . Lanes
were loaded with the RNA from individual mice killed 24 h after applica-
tion . (Lanes 1 and 2) Nontreated mice ; (lanes 3 and 4) mice treated with
the solvent acetone/oil; (lanes 5 and 6) mice treated with1%TNCB; (lanes
7 and 8) sensitized mice, treated with 1% TNCB ; (lanes 9 and 10) sensi-
tized mice treated with 1% TNCB and treated with nonimmune (9) or
antiTNF (10) rabbit IgG. The position of theTNF mRNA is indicated
by an arrow.
676 Tumor Necrosis Factor and Contact Hypersensitivity
ofTNCB to nonsensitized mice showed a clear-cut increase
of the TNF mRNA level 0.5 h after application, which per-
sisted without gross change for 72 h (data not shown) . Similar
accumulation of TNT mRNA were observed after applica-
tion of oxazolone (data not shown) .
The accumulation of TNF mRNA during CH was in-
fluenced by TNF itself, since it was prevented by antiTNF
antibody (Fig. 2, lanes 9 and 10) ; in four mice undergoing
CH and treated with antiTNF IgG, the TNFmRNA was
<3% of that of the mice treated with nonimmune IgG, as
seen by densitometric analysis of the Northern blots .
The cellular origin of TNF mRNA was explored by in
situ hybridization . As seen in Fig . 3, theTNCB application
to the inner face of the ear greatly increased the hybridiza-
tion of the 35S-labeled TNF probe to the ear, the basal layer
of the epidermis being the most intensively labeled (Fig . 3,
A-D) . This pattern of hybridization was further increased
by the application of TNCB to sensitized mice (Fig. 3, E
and F) . Cells bearing grains were detected in the basal layer
ofkeratinocytes (Fig. 3 G) and also in the dermis, which ap-
peared to be polymorphonuclear leukocytes (not shown) .
Figure 3 .
￿
TNFmRNArevealed byin situ hybridization. (A-F) Frozen
ear sections, with on the left (A, C, andE) the phasecontrast microscopy,
and on the right (B, D, and F), the film autoradiograph. (A and B) Mice
treated with solvent only; (C and D) nonsensitized mice treated with 1%
TNCB; (E and F) sensitized mice treated with 1% TNCB . Grains are
present overDand Fand are more dense over the epidermis. (G) Autoradio-
graph performed upon a paraffin-embedded ear section showing a group
ofbasal keratinocytes bearing grains (wide arrow) with isolated or groups
of necrotic keratinocytes in the proximity (thin arrows) .
Priming
Challenge
Treatment
(TNCB)
Epithelial"
necrosis
Dermalt
infiltrates
91 0
OS - <1 <1
0.1 - 1 1
1.0 - 22 (8) 23 (9)
1.0 n Ig 12 (3) 13 (2)
1.0 a TNF <111 2 (2)11
+ 0.1 n Ig 4 (3) 9 (8)
+ 0.1 a TNF 1 (2) 3 (2)
+ 1.0 n Ig 32 (14) 59 (8)
+ 1.0 a TNF 16 (10)11 21 (6)11Table 3 .
￿
Correlation between TNCB-induced IR and TNF
mRNA Accumulation
Four individual mice were examined as in Table 1 . TNF mRNA is ex-
pressed as the median (range) in arbitrary units ofthe densitometric anal-
ysis of the Northern blots .
Correlation between Expression ofTNFmRNA andCH.
￿
The
intensity of theCH varies greatly in different anatomical sites .
As shown on Table 3, it is severe in the ear, intermediate in
the trunk, and completely absent in the foot pad skin . This
response correlated with the TNT mRNA accumulation after
application ofTNCB; TNF rnRNA was most abundant in
the ear and undetectable in the foot pad (Table 3) .
Discussion
The epicutanous application of certain chemicals on the
skin can induce two types of inflammatory reactions ; the IR
and theCH, in nonsensitized and sensitized subjects, respec-
tively. In one case, the reaction results from some inflamma-
tory properties of the chemical, while in the other, it is
amplified by the activation of previously sensitized T lym-
phocytes. These two types of reactions are extremely difficult
to discriminate on histological sections and this has been a
long standing diagnostic concern (1-3, 6) . The present results
indicate that these morphological similarities are due to the
involvement of the same effector mechanism, in whichTNF
plays a key role; this conclusion is similar to that obtained
in several other inflammatory or immunopathological reac-
tions, such as the endotoxinemia (19), Graft-vs.-host-disease
(20),BCG granuloma (21), cerebral malaria (13), or the fibrotic
reactions induced by a drug (bleomycin) (22) or silica parti-
cles (23) . In these reactions, T lymphocytes and macrophages
appear to be the major source ofTNF, while in the present
experiments, it is the keratinocytes .
There are three lines of evidence that argue in favor of a
major role ofTNF in both IR and CH ; first, these reactions
are associated with a marked rise in the TNFmRNA level;
second, they are considerably reduced or abrogated by anti-
TNF antibody; third, a continuous hypodermal infusion of
TNF can reproduce many of the dermal or epidermal fea-
tures of CH, notably epidermal necrosis, dermal leukocytec
infiltration, and hemorrhagic necrosis (24) . TNF, which is
recognized as a powerful mediator of inflammatory reaction,
might induce these alterations either directly, since it can react
with a wide range ofcell types (19), or indirectly by the acti-
vation of several other cells. Thus, epidermal cell necrosis might
be due to a direct toxic effect of TNF, since the toxicity of
TNF for epithelial cells is documented in vitro (25) . Simi-
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larly, edema and hemorrhagic necrosis might be due to a toxic
effect of TNF on endothelial cells since TNF can damage
endothelial cells in vitro (26) . In addition, these lesions are
aggravated by the sequestration ofleukocytes : there is indeed
an obvious correlation between the increase in ear thickness
(i.e., in great part due to dermal edema) and the accumula-
tion of leukocytes within the dermis (i .e ., see tables 1 and
2) . Cell adhesion molecules are most likely involved in leu-
kocyte sequestration, andTNF is indeed one of the cytokines
that can increase the expression of cell adhesion molecules
upon endothelial cells and leukocytes (27) . Overexpression
of the intercellular adhesion molecule 1 (ICAM-1) has in-
deed been reported as an early event in CH (28), and ad-
ministration of anti-LFA-1 mAb blocks both the CH and
IR (our unpublished observation) .
The in situ hybridization data suggest that several cell types
are accumulating TNFmRNA (and presumably producing
TNF) during IR orCH, the quantitatively most important
being the basal keratinocyte. Production of ILA by epidermal
cells has been extensively documented (reviewed in reference
29), and accumulation ofIll-camRNA during IR and CH
was detectable on Northern blots (not shown) . In contrast,
information concerning epidermal TNF is relatively scarce;
a squamous cell epidermal carcinoma has been reported to
contain TNF mRNA (30) . Production ofTNF by the basal
keratinocytes appears to occur in close correlation and prox-
imity with a massive necrosis of these epithelial cells (see Fig.
3) . Since antiTNF antibody abrogates the TNF rnRNA ac-
cumulation (Fig . 2, lanes 9 and 10), this implies that TNF
influences its own synthesis during CH and is therefore in-
volved in an auto-amplification process. In this respect, it is
of interest to recall that TNF is an inducer of its own syn-
thesis in macrophages (21) . Studies of keratinocytes in vitro
should help clarify whether this TNF-induced auto-amplifi-
cation process can occur with the keratinocytes alone .
Of the other cytokines explored in this work, two, IL-2
and IFN-.y , are produced rather exclusively by lymphocytes,
while IL3 and GM-CSF are produced by both the cells of
the immune system and the epidermal cells (reviewed in ref-
erence 29) . IL2 and IFN-y might be involved in various phases
ofT lymphocyte activation and proliferation, while IL-3 and
GM-CSF might be involved in the sequestration and local
growth of leukocytes . Antibody capable of blocking the ac-
tion ofIFN-y or GM-CSF FL-3 had moderate inhibitory effects
on theCH, indicating that these cytokines exert some com-
plementary role in the full expression of the CH . A similar
decrease oftheDTH reaction by treatment with anti-IFN-'Y
antibody has already been reported (31) . Anti-IL-2R mAb
had no effect upon the CH when given immediately before
the challenge, while it has been reported to exert an inhibi-
tory effect upon aDTH reaction (32), a difference that might
be related to the implication ofdifferent T lymphocyte subset
in these two reactions .
The present study is also relevant with respect to the con-
siderable differences in the response of the skin to hapten ap-
plication at different anatomical sites (ear, back, foot pad) .
Differences in responsiveness have been related to differences
in the density ofvaso-amine-secreting cells such as basophils
Organ
Epithelial
necrosis
Dermal
leukocytes TNF mRNA
Ear 49 (8) 34 (12) 72
Back 41 (12) 18 (2) 5
Foot pad - 1 <1and mastocytes (33, 34) or to differences in the density of
epidermal Langerhans cells (35) or epidermalThy-1 cells (36).
The present study provides an alternative or additional in-
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